Sun BioPharma's Reverse Merger Round

Sun BioPharma raised a round of funding on September 04, 2015. Investors include Cimarron Medical.

Sun BioPharma is a drug development company committed to providing cancer patients with rapid access to therapeutics. SUN-101 is a polyamine analogue which accumulates in the exocrine cells of the pan…

Articles about Sun BioPharma's Reverse Merger Round: